Maximus, Inc. $MMS Shares Sold by Assenagon Asset Management S.A.

Key Points

• Assenagon Asset Management S.A. drastically reduced its stake in Maximus, Inc. by 97.1%, leaving it with just 5,877 shares after selling 197,684 shares in the second quarter.
• Maximus has received a Strong Buy rating from analysts, with a consensus target price of $90.00 per share following a recent report by Zacks Research.
• The company reported earnings of $2.16 per share for the last quarter, exceeding expectations, and has set its FY 2025 guidance at 7.350-7.550 EPS.

Assenagon Asset Management S.A. trimmed its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 97.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,877 shares of the health services provider's stock after selling 197,684 shares during the period. Assenagon Asset Management S.A.'s holdings in Maximus were worth $413,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Exchange Traded Concepts LLC grew its holdings in Maximus by 2.0% during the second quarter. Exchange Traded Concepts LLC now owns 11,870 shares of the health services provider's stock worth $833,000 after acquiring an additional 228 shares during the period. Wealth Enhancement Advisory Services LLC acquired a new stake in Maximus during the second quarter worth about $577,000. Sivia Capital Partners LLC acquired a new stake in Maximus during the second quarter worth about $204,000. Reinhart Partners LLC. grew its holdings in Maximus by 0.3% during the second quarter. Reinhart Partners LLC. now owns 913,856 shares of the health services provider's stock worth $64,154,000 after acquiring an additional 2,345 shares during the period. Finally, Pallas Capital Advisors LLC acquired a new stake in Maximus in the second quarter valued at approximately $211,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Zacks Research raised Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the stock. According to MarketBeat, Maximus presently has a consensus rating of "Strong Buy" and an average target price of $90.00.

Maximus Stock Performance

NYSE MMS opened at $88.04 on Monday. The company has a market cap of $4.96 billion, a PE ratio of 16.21 and a beta of 0.61. The stock's 50 day simple moving average is $83.24 and its 200-day simple moving average is $74.64. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.94. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.77. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The business's quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, equities research analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Sunday, August 31st. Investors of record on Friday, August 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's dividend payout ratio (DPR) is presently 22.10%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.